Tratamento híbrido das doenças do arco aórtico
Fuente:
Redalyc
Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | pt |
| Published: |
Sociedade Brasileira de Cirurgia Cardiovascular
2014
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1876449306261585920 |
|---|---|
| author | Patrick Bastos Metzger |
| author_facet | Patrick Bastos Metzger |
| contents | Tratamento híbrido das doenças do arco aórtico Patrick Bastos Metzger Fabio Henrique Rossi Samuel Martins Moreira Mario Issa Nilo Mitsuru Izukawa Jarbas J. Dinkhuysen Domingos Spina Neto Antônio Massamitsu Kambara Medicina thoracic aneurysm dissecting aortic aneurysm aortic diseases Introduction: The management of thoracic aortic disease involving the ascending aorta, aortic arch and descending thoracic aorta are technically challenging and is an area in constant development and innovation. Objective: To analyze early and midterm results of hybrid treatment of arch aortic disease. Methods: Retrospective study of procedures performed from January 2010 to December 2012. The end points were the technical success, therapeutic success, morbidity and mortality, neurologic outcomes, the rate of endoleaks and reinterventions. Results: A total of 95 patients treated for thoracic aortic diseases in this period, 18 underwent hybrid treatment and entered in this study. The average ages were 62.3 years. The male was present in 66.7%. The technical and therapeutic success was 94.5% e 83.3%. The perioperative mortality rate of 11.1%. There is any death during one-year follow-up. The reoperation rates were 16.6% due 2 cases of endoleak Ia and one case of endoleak II. There is any occlusion of anatomic or extra anatomic bypass during follow up. Conclusion: In our study, the hybrid treatment of aortic arch disease proved to be a feasible alternative of conventional surgery. The therapeutic success rates and re- interventions obtained demonstrate the necessity of thorough clinical follow-up of these patients in a long time. 2014 artículo científico 0102-7638 https://www.redalyc.org/articulo.oa?id=398941895009 pt http://www.redalyc.org/revista.oa?id=3989 Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery application/pdf Sociedade Brasileira de Cirurgia Cardiovascular Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery (Brasil) Num.4 Vol.29 |
| format | Artículo científico |
| id | redalyc_398941895009 |
| institution | Redalyc |
| language | pt |
| publishDate | 2014 |
| publisher | Sociedade Brasileira de Cirurgia Cardiovascular |
| spellingShingle | Tratamento híbrido das doenças do arco aórtico Patrick Bastos Metzger Medicina thoracic aneurysm dissecting aortic aneurysm aortic diseases Tratamento híbrido das doenças do arco aórtico Patrick Bastos Metzger Fabio Henrique Rossi Samuel Martins Moreira Mario Issa Nilo Mitsuru Izukawa Jarbas J. Dinkhuysen Domingos Spina Neto Antônio Massamitsu Kambara Medicina thoracic aneurysm dissecting aortic aneurysm aortic diseases Introduction: The management of thoracic aortic disease involving the ascending aorta, aortic arch and descending thoracic aorta are technically challenging and is an area in constant development and innovation. Objective: To analyze early and midterm results of hybrid treatment of arch aortic disease. Methods: Retrospective study of procedures performed from January 2010 to December 2012. The end points were the technical success, therapeutic success, morbidity and mortality, neurologic outcomes, the rate of endoleaks and reinterventions. Results: A total of 95 patients treated for thoracic aortic diseases in this period, 18 underwent hybrid treatment and entered in this study. The average ages were 62.3 years. The male was present in 66.7%. The technical and therapeutic success was 94.5% e 83.3%. The perioperative mortality rate of 11.1%. There is any death during one-year follow-up. The reoperation rates were 16.6% due 2 cases of endoleak Ia and one case of endoleak II. There is any occlusion of anatomic or extra anatomic bypass during follow up. Conclusion: In our study, the hybrid treatment of aortic arch disease proved to be a feasible alternative of conventional surgery. The therapeutic success rates and re- interventions obtained demonstrate the necessity of thorough clinical follow-up of these patients in a long time. 2014 artículo científico 0102-7638 https://www.redalyc.org/articulo.oa?id=398941895009 pt http://www.redalyc.org/revista.oa?id=3989 Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery application/pdf Sociedade Brasileira de Cirurgia Cardiovascular Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery (Brasil) Num.4 Vol.29 |
| title | Tratamento híbrido das doenças do arco aórtico |
| topic | Medicina thoracic aneurysm dissecting aortic aneurysm aortic diseases |
| url | https://www.redalyc.org/articulo.oa?id=398941895009 |